Latest iPhones by Apple Inc. got long lines of people, who are eager to buy this new device. According to the company, new iPhones have surpassed the sale of 10 million units in the first three days of the start of sale. Interestingly, consumers are going for iPhone 6, 7 times more than the iPhone 6 Plus. This is the second time that the company has sold two new iPhones at the same time. Last year, Apple sold nine million units of iPhone 5s and iPhone 5c in the same time of start of sale. Continue reading Apple’s new iPhones have gone above expectations
New report from global cancer experts outlines barriers to cancer care and recent achievements in the three countries with more than half of the world’s deaths from cancer.
The Lancet Oncology
The Lancet Oncology today [Friday 11 April] publishes a major new Commission examining the challenges to effective cancer control in China, India, and Russia – which together experience 46% of all new cancers worldwide, and account for more than half (52%) of all cancer deaths globally. The Commission was led by Professor Paul Goss, of Harvard Medical School and Massachusetts General Hospital Cancer Center, USA, in collaboration with over 40 leading cancer experts from the regions studied, and across the world.
At the same time, the journal also publishes a three part Series on cancer burden and health systems in India, coordinated by Professor Richard Sullivan, of King’s College London, UK, and with contributions from many of India’s leading cancer experts, including Professor C S Pramesh, of the Tata Memorial Centre, Mumbai, India, and Professor Mohandas Mallath, of the Tata Medical Center, Kolkata, India.
Mojiang paramyxovirus (MojV) is a newly discovered dreadful virus in Yunnan Province of China. It has genetic similarity to henipaviruses and other members of family Paramyxoviridae. Its potential reservoir is rodents (rats).
Following notes have been taken from Science NOW’s article “A New Killer Virus in China?” (http://goo.gl/eCNZnZ). Continue reading Newly discovered dreadful virus in China
Over the last 20 years, China has more than halved its tuberculosis (TB) prevalence, with rates falling from 170 to 59 per 100 000 population. This unrivalled success has been driven by a massive scale-up of the directly observed, short-course (DOTS) strategy, from half the population in the 1990s to the entire country after 2000, according to findings from a 20-year-long analysis of national survey data, published in The Lancet.
“One of the key global TB targets set by the Stop TB Partnership aims to reduce tuberculosis prevalence by 50% between 1990 and 2015. This study in China is the first to show the feasibility of achieving such a target, and China achieved this 5 years earlier than the target date”, says study leader Dr Yu Wang from the Chinese Center for Disease Control and Prevention in Beijing, China.
Nanoparticles capable of delivering drugs to specifically targeted cancer cells have been created by a group of researchers from China.
The multifunctional ‘smart’ gold nanoshells could lead to more effective cancer treatments by overcoming a major limitation of modern chemotherapy techniques—the ability to target cancer cells specifically and leave healthy cells untouched.